-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Biomedical Engineering
- Cardiology
- Clinical Trials
- Clinics
- Consumer Products
- Counterfeit Products
- Critical Care Medicine
- Dentistry
- Dermatology
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA 2013
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Home Care
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Nephrology
- Neurology
- Nursing
- OBGYN
- Oncology
- Ophthalmology
- Orthopaedic Surgery
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Physical Medicine
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Risk Manager
- Surgery
- Uncategorized
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
Tag Archives: extended-cycle oral contraceptive
Introvale levonorgestrel and ethinyl estradiol Tablets Recall
Translation Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall – Packaging Flaw AUDIENCE: Consumer, Pharmacy ISSUE: Sandoz notified the public that it issued a voluntary recall of 10 lots of its generic oral contraceptive Introvale in the US, following a recent … Continue reading
Posted in Consumer Products, FDA 2012, FDA Recall, Pharmacy
Tagged Birth Control Pills, Consumer, Consumer Products, drug risks, ethinyl estradiol, extended-cycle oral contraceptive, Family Practice, FDA recall, Introvale, Introvale levonorgestrel and ethinyl estradiol Tablets Recall, levonorgestrel, Pharmacy, Recall, Sandoz, tablets
Comments Off